These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

81 related articles for article (PubMed ID: 7466717)

  • 1. Study of the clinical effectivity of Sanegyt.
    Dobi S; Siró B; Szabó T; Petrányi G
    Ther Hung; 1980; 28(2):60-6. PubMed ID: 7466717
    [No Abstract]   [Full Text] [Related]  

  • 2. Blood-pressure depressing action of intravenous Sanegyt (haemodynamic examinations).
    Herpai Z; Simonyi J
    Ther Hung; 1980; 28(4):181-5. PubMed ID: 7209852
    [No Abstract]   [Full Text] [Related]  

  • 3. [Sanegyt therapy of moderately severe and severe arterial hypertension].
    Stankusheva G; Elenkova A
    Vutr Boles; 1981; 20(2):81-7. PubMed ID: 7257337
    [No Abstract]   [Full Text] [Related]  

  • 4. Blood pressure fall obtained with Sanegyt.
    Síró B; Dobi S; Szabó T; Petrányi
    Ther Hung; 1977; 25(4):134-44. PubMed ID: 605412
    [No Abstract]   [Full Text] [Related]  

  • 5. [Studies on hemodynamics after intravenous application of dihydralazine and guanethidine in hypertonic patients].
    Juchems R; Ammerschläger G
    Arzneimittelforschung; 1967 May; 17(5):587-91. PubMed ID: 4873896
    [No Abstract]   [Full Text] [Related]  

  • 6. The influence of renal function on plasma levels, urinary excretion, metabolism, and antihypertensive effect of guanethidine (ismelin) in man.
    Rahn KH
    Clin Nephrol; 1973; 1(1):14-23. PubMed ID: 4767350
    [No Abstract]   [Full Text] [Related]  

  • 7. [The effect of several hypotensors on the working blood pressure and on the output in subjects with stage II hypertension (author's transl)].
    Chrástek J; Matousek O
    Cas Lek Cesk; 1977 Feb; 116(3):80-4. PubMed ID: 844063
    [No Abstract]   [Full Text] [Related]  

  • 8. Changing the timing of antihypertensive therapy to reduce nocturnal blood pressure in CKD: an 8-week uncontrolled trial.
    Minutolo R; Gabbai FB; Borrelli S; Scigliano R; Trucillo P; Baldanza D; Laurino S; Mascia S; Conte G; De Nicola L
    Am J Kidney Dis; 2007 Dec; 50(6):908-17. PubMed ID: 18037091
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Short term effectiveness and hemodynamic actions of guanadrel, a new sympatholytic drug.
    Pascual AV; Julius S
    Curr Ther Res Clin Exp; 1972 Jul; 14(7):333-42. PubMed ID: 4625513
    [No Abstract]   [Full Text] [Related]  

  • 10. Nephroprotection by antihypertensive agents.
    Schmieder RE
    J Cardiovasc Pharmacol; 1994; 24 Suppl 2():S55-64. PubMed ID: 7898095
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Comparative clinical study of guanoxan and guanethidine].
    Veldeman W
    Brux Med; 1965 Jun; 45(24):673-9. PubMed ID: 5319770
    [No Abstract]   [Full Text] [Related]  

  • 12. [The effect of guanethidine and reserpine in angiotensin sensitivity in man].
    Kállay K; Káldor A; Gachályi B; Sebestyén K; Földvári A
    Orv Hetil; 1974 Dec; 115(49):2917-9. PubMed ID: 4376593
    [No Abstract]   [Full Text] [Related]  

  • 13. [Physiopathological deliberations on the significance of long-term therapy for hypertension].
    Kiesewetter E
    Wien Klin Wochenschr; 1967 Nov; 79(44):812-5. PubMed ID: 5589334
    [No Abstract]   [Full Text] [Related]  

  • 14. Antihypertensive and renoprotective efficacy and safety of losartan. A long-term study in children with renal disorders.
    Ellis D; Moritz ML; Vats A; Janosky JE
    Am J Hypertens; 2004 Oct; 17(10):928-35. PubMed ID: 15485756
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Decline of renal function is associated with proteinuria and systolic blood pressure in the morning in diabetic nephropathy.
    Suzuki H; Kanno Y; Nakamoto H; Okada H; Sugahara S
    Clin Exp Hypertens; 2005; 27(2-3):129-38. PubMed ID: 15835375
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antiproteinuric and blood pressure-lowering effects of a fixed-dose combination of losartan and hydrochlorothiazide in hypertensive patients with stage 3 chronic kidney disease.
    Abe M; Okada K; Maruyama T; Matsumoto K
    Pharmacotherapy; 2009 Sep; 29(9):1061-72. PubMed ID: 19698011
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Effect of ismelin on cerebral blood circulation in patients with hypertensive disease].
    Vinichuk SM; Dukhina MA
    Vrach Delo; 1967; 9():53-5. PubMed ID: 5621781
    [No Abstract]   [Full Text] [Related]  

  • 18. Guanethidine.
    Woosley RL; Nies AS
    N Engl J Med; 1976 Nov; 295(19):1053-7. PubMed ID: 972658
    [No Abstract]   [Full Text] [Related]  

  • 19. A comparative clinical trial of guanoxan and guanethidine in essential hypertension.
    Ruedy J; Davies RO
    Clin Pharmacol Ther; 1967; 8(1):38-47. PubMed ID: 5334083
    [No Abstract]   [Full Text] [Related]  

  • 20. Antihypertensive treatment and glomerular size selectivity in hypertensive patients with renal parenchymal disease and proteinuria.
    Shand BI; Lewis JG; Elder PA; Agarwal M
    Clin Nephrol; 2002 Oct; 58(4):321-4. PubMed ID: 12400851
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.